Evidence map›Paper›PMID 41428006›Full record

ArticleEuropean journal of clinical pharmacology2025

Severe loperamide misuse in a patient with anxiety - a complication of p-glycoprotein interaction with paroxetine.

Katharina von Fabeck, Jean Claude Alvarez, Emuri Abe, Nicolas Simon

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katharina von FabeckDepartment of Clinical Pharmacology, Institut de Neurosciences de la Timone, Aix Marseille Univ, APHM, UMR7289 CNRS, Hop Sainte Marguerite, CAP-TV, Marseille, 13005, France. katharina.moenikes@ap-hm.fr.
Jean Claude AlvarezDepartment of Pharmacology and Toxicology, CESP, Team MOODS, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, Paris-Saclay/Versailles University, Inserm, Garches, U-1018, 92380, France.
Emuri AbeDepartment of Pharmacology and Toxicology, CESP, Team MOODS, Raymond Poincaré hospital, GHU AP-HP.Paris-Saclay, Paris-Saclay/Versailles University, Inserm, Garches, U-1018, 92380, France.
Nicolas SimonDepartment of Clinical Pharmacology, Institut de Neurosciences de la Timone, Aix Marseille Univ, APHM, UMR7289 CNRS, Hop Sainte Marguerite, CAP-TV, Marseille, 13005, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AddictionAnxiety self-medicationLoperamide misuseParoxetineP-glycoprotein interaction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.